142 related articles for article (PubMed ID: 7667607)
41. [Hyperprolactinaemia--pitfalls in PRL assessment].
Zgliczyński W; Zdunowski P
Endokrynol Pol; 2005; 56(6):980-5. PubMed ID: 16821223
[TBL] [Abstract][Full Text] [Related]
42. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
Giusti M; Lomeo A; Torre R; Sghedoni D; Mazzocchi G; Durante R; Giordano G
Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
[TBL] [Abstract][Full Text] [Related]
43. Determination of prolactin: the macroprolactin problem.
Fahie-Wilson M; Smith TP
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
[TBL] [Abstract][Full Text] [Related]
44. [Prolactin variants in serum and amniotic fluid of women with ovulatory hyperprolactinemia].
Larrea F; Escorza A; Méndez I; Ruiz JE; Valero A; Cravioto MC
Rev Invest Clin; 1991; 43(3):245-51. PubMed ID: 1818370
[TBL] [Abstract][Full Text] [Related]
45. Pituitary macroadenomas associated with hyperprolactinaemia: immunocytochemical and in-situ hybridization studies.
McNicol AM; Walker E; Farquharson MA; Teasdale GM
Clin Endocrinol (Oxf); 1991 Sep; 35(3):239-44. PubMed ID: 1742881
[TBL] [Abstract][Full Text] [Related]
46. Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men.
Romeo JH; Dombrowski R; Kwak YS; Fuehrer S; Aron DC
Clin Endocrinol (Oxf); 1996 Nov; 45(5):571-5. PubMed ID: 8977754
[TBL] [Abstract][Full Text] [Related]
47. Interpretation of Serum Gonadotropin Levels in Hyperprolactinaemia.
Abbara A; Clarke SA; Nesbitt A; Ali S; Comninos AN; Hatfield E; Martin NM; Sam AH; Meeran K; Dhillo WS
Neuroendocrinology; 2018; 107(2):105-113. PubMed ID: 29660734
[TBL] [Abstract][Full Text] [Related]
48. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
Fahie-Wilson MN; Soule SG
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
[TBL] [Abstract][Full Text] [Related]
49. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
50. Macroprolactinaemia: a biological diagnostic strategy from the study of 222 patients.
Parlant-Pinet L; Harthé C; Roucher F; Morel Y; Borson-Chazot F; Raverot G; Raverot V
Eur J Endocrinol; 2015 Jun; 172(6):687-95. PubMed ID: 25755230
[TBL] [Abstract][Full Text] [Related]
51. Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
Whyte MB; Pramodh S; Srikugan L; Gilbert JA; Miell JP; Sherwood RA; McGregor AM; Aylwin SJ
Pituitary; 2015 Jun; 18(3):319-25. PubMed ID: 24879500
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hyperprolactinaemia in female premenopausal blood donors.
Alpañés M; Sanchón R; Martínez-García MÁ; Martínez-Bermejo E; Escobar-Morreale HF
Clin Endocrinol (Oxf); 2013 Oct; 79(4):545-9. PubMed ID: 23445257
[TBL] [Abstract][Full Text] [Related]
53. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
Larrea F; Escorza A; Valero A; Hernandez L; Cravioto MC; Diaz-Sanchez V
J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
[TBL] [Abstract][Full Text] [Related]
55. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
56. The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.
Valcavi R; Harris PE; Foord SM; Dieguez C; Evans PJ; Peters JR; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1985 Aug; 23(2):139-46. PubMed ID: 4053412
[TBL] [Abstract][Full Text] [Related]
57. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.
Colao A; Di Sarno A; Guerra E; Pivonello R; Cappabianca P; Caranci F; Elefante A; Cavallo LM; Briganti F; Cirillo S; Lombardi G
Clin Endocrinol (Oxf); 2007 Sep; 67(3):426-33. PubMed ID: 17573902
[TBL] [Abstract][Full Text] [Related]
58. Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin.
Miyai K; Ichihara K; Kondo K; Mori S
Clin Endocrinol (Oxf); 1986 Nov; 25(5):549-54. PubMed ID: 3621622
[TBL] [Abstract][Full Text] [Related]
59. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
Hattori N; Inagaki C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
[TBL] [Abstract][Full Text] [Related]
60. The proportion of glycosylated prolactin in serum is decreased in hyperprolactinemic states.
Hashim IA; Aston R; Butler J; McGregor AM; Smith CR; Norman M
J Clin Endocrinol Metab; 1990 Jul; 71(1):111-5. PubMed ID: 2370290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
